Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Videos
The Mechanism of Action of CDK4/6 Inhibitors
FEATURING:
Matthew P. Goetz, MD
January 10, 2018
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
The Use of Chemotherapy in the Metastatic Setting
FEATURING:
Matthew P. Goetz, MD
January 6, 2018
SABCS 2017 Highlights
,
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
FEATURING:
Matthew P. Goetz, MD
January 2, 2018
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
Questions About Treating Patients Using a CDK4/6 Inhibitor
FEATURING:
Matthew P. Goetz, MD
December 29, 2017
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
FEATURING:
Matthew P. Goetz, MD
December 25, 2017
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
Hot Topics at SABCS 2017
FEATURING:
Hope S. Rugo, MD
December 21, 2017
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer
FEATURING:
Hope S. Rugo, MD
December 17, 2017
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer
FEATURING:
Hope S. Rugo, MD
December 13, 2017
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
What Differentiates Abemaciclib, Ribociclib, and Palbociclib?
FEATURING:
Hope S. Rugo, MD
December 9, 2017
Breast Cancer
,
SABCS 2017 Highlights
,
SABCS Highlights
Watch Video
Page 13 of 20
10
11
12
13
14
15
16
